Ignite Creation Date:
2025-12-25 @ 2:03 AM
Ignite Modification Date:
2025-12-26 @ 1:59 AM
Study NCT ID:
NCT04064060
Status:
RECRUITING
Last Update Posted:
2025-11-12
First Post:
2019-08-09
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study to Evaluate Long-term Safety in Participants Who Have Participated in Other Luspatercept (ACE-536) Clinical Trials
Sponsor:
Organization:
Raw JSON
{'hasResults': False, 'derivedSection': {'miscInfoModule': {'versionHolder': '2025-12-24'}, 'conditionBrowseModule': {'meshes': [{'id': 'D009190', 'term': 'Myelodysplastic Syndromes'}, {'id': 'D017086', 'term': 'beta-Thalassemia'}, {'id': 'D009196', 'term': 'Myeloproliferative Disorders'}], 'ancestors': [{'id': 'D001855', 'term': 'Bone Marrow Diseases'}, {'id': 'D006402', 'term': 'Hematologic Diseases'}, {'id': 'D006425', 'term': 'Hemic and Lymphatic Diseases'}, {'id': 'D013789', 'term': 'Thalassemia'}, {'id': 'D000745', 'term': 'Anemia, Hemolytic, Congenital'}, {'id': 'D000743', 'term': 'Anemia, Hemolytic'}, {'id': 'D000740', 'term': 'Anemia'}, {'id': 'D006453', 'term': 'Hemoglobinopathies'}, {'id': 'D030342', 'term': 'Genetic Diseases, Inborn'}, {'id': 'D009358', 'term': 'Congenital, Hereditary, and Neonatal Diseases and Abnormalities'}]}, 'interventionBrowseModule': {'meshes': [{'id': 'C000621232', 'term': 'luspatercept'}]}}, 'protocolSection': {'designModule': {'phases': ['PHASE3'], 'studyType': 'INTERVENTIONAL', 'designInfo': {'allocation': 'NA', 'maskingInfo': {'masking': 'NONE'}, 'primaryPurpose': 'TREATMENT', 'interventionModel': 'SINGLE_GROUP'}, 'enrollmentInfo': {'type': 'ESTIMATED', 'count': 665}}, 'statusModule': {'overallStatus': 'RECRUITING', 'startDateStruct': {'date': '2019-08-12', 'type': 'ACTUAL'}, 'expandedAccessInfo': {'hasExpandedAccess': False}, 'statusVerifiedDate': '2025-11', 'completionDateStruct': {'date': '2028-05-12', 'type': 'ESTIMATED'}, 'lastUpdateSubmitDate': '2025-11-11', 'studyFirstSubmitDate': '2019-08-09', 'studyFirstSubmitQcDate': '2019-08-19', 'lastUpdatePostDateStruct': {'date': '2025-11-12', 'type': 'ESTIMATED'}, 'studyFirstPostDateStruct': {'date': '2019-08-21', 'type': 'ACTUAL'}, 'primaryCompletionDateStruct': {'date': '2028-05-12', 'type': 'ESTIMATED'}}, 'outcomesModule': {'primaryOutcomes': [{'measure': 'Adverse Events (AEs)', 'timeFrame': 'From enrollment until at least 42 Day Safety Follow-up Phase', 'description': 'Type, frequency, severity of AEs, relationship of treatment emergent adverse events to luspatercept'}, {'measure': 'Number of participants progressing to high/very high risk MDS or AML.', 'timeFrame': 'Enrollment to Long-term post-treatment follow-up (Approximately, 5 years)', 'description': 'Progression to high/very high-risk myelodysplastic syndrome (MDS) or acute myeloid leukemia (AML) (MDS and myelofibrosis \\[MF\\] only).'}, {'measure': 'Percentage of participants progressing to high/very high risk MDS or AML', 'timeFrame': 'Enrollment to Long-term post-treatment follow-up (Approximately, 5 years)', 'description': 'Progression to high/very high-risk myelodysplastic syndrome (MDS) or acute myeloid leukemia (AML) (MDS and myelofibrosis \\[MF\\] only)'}, {'measure': 'Number of participants developing other malignancies/pre-malignancies', 'timeFrame': 'Enrollment to Long-term post-treatment follow-up (Approximately, 5 years)', 'description': 'Development of other malignancies/pre-malignancies'}, {'measure': 'Percentage of participants developing other malignancies/pre-malignancies', 'timeFrame': 'Enrollment to Long-term post-treatment follow-up (Approximately, 5 years)', 'description': 'Development of other malignancies/pre-malignancies'}], 'secondaryOutcomes': [{'measure': 'Overall Survival', 'timeFrame': 'Enrollment to Long-term post-treatment follow-up (Approximately, 5 years)', 'description': 'Time from date of randomization until death from any cause'}, {'measure': 'Number of participants developing treatment emergent extramedullary hematopoiesis (EMH) masses', 'timeFrame': 'Enrollment to Long-term post-treatment follow-up (Approximately, 5 years)'}, {'measure': 'Percentage of participants developing treatment emergent EMH masses', 'timeFrame': 'Enrollment to Long-term post-treatment follow-up (Approximately, 5 years)'}]}, 'oversightModule': {'oversightHasDmc': False, 'isFdaRegulatedDrug': True, 'isFdaRegulatedDevice': False}, 'conditionsModule': {'keywords': ['ACE-536', 'Luspatercept', 'MDS', 'Beta-thalassemia', 'Myeloproliferative neoplasm (MPN)-associated myelofibrosis'], 'conditions': ['Myelodysplastic Syndromes (MDS)', 'Beta-thalassemia', 'Myeloproliferative Neoplasm(MPN)-Associated Myelofibrosis']}, 'referencesModule': {'seeAlsoLinks': [{'url': 'https://www.bms.com/researchers-and-partners/clinical-trials-and-research.html', 'label': 'BMS Clinical Trial Information'}]}, 'descriptionModule': {'briefSummary': 'A Phase 3b, open-label, single-arm, rollover study to evaluate the long-term safety of luspatercept, to the following participants:\n\n* Participants receiving luspatercept on a parent protocol at the time of their transition to the rollover study, who tolerate the protocol-prescribed regimen in the parent trial and, in the opinion of the investigator, may derive clinical benefit from continuing treatment with luspatercept\n* Participants in the follow-up phase previously treated with luspatercept or placebo in the parent protocol will continue into long-term post-treatment follow-up in the rollover study until the follow-up commitments are met\n* The study design is divided into the Transition Phase, Treatment Phase and Follow-up Phase. Participants will enter transition phase and depending on their background will enter either the treatment phase or the Long-term Post-treatment Follow-up (LTPTFU) phase\n* Transition Phase is defined as one Enrollment visit\n* Treatment Phase: For participants in luspatercept treatment the dose and schedule of luspatercept in this study will be the same as the last dose and schedule in the parent luspatercept study. This does not apply to participants that are in long-term follow-up from the parent protocol\n* Follow-up Phase includes:\n\n \\- 42 Day Safety Follow-up Visit\n* During the Safety Follow up, the participants will be followed for 42 days after the last dose of luspatercept, for the assessment of safety-related parameters and adverse event (AE) reporting\n\n \\- Long-term Post-treatment Follow-up (LTPTFU) Phase\n* Participants will be followed for overall survival every 6 months for at least 5 years from first dose of luspatercept in the parent protocol, or 3 years of post-treatment from last dose, whichever occurs later, or until death, withdrawal of consent, study termination, or until a subject is lost to follow-up. Participants will also be monitored for progression to AML or any malignancies/pre-malignancies. New anticancer or disease related therapies should be collected at the same time schedule\n\nParticipants transitioning from a parent luspatercept study in post-treatment follow-up (safety or LTPTFU) will continue from the same equivalent point in this rollover study.\n\nThe ACE-536-LTFU-001 rollover study will be terminated, and relevant participants will discontinue from the study when all participants fulfill 5 years on the study, including treatment and follow-up.'}, 'eligibilityModule': {'sex': 'ALL', 'stdAges': ['ADULT', 'OLDER_ADULT'], 'minimumAge': '18 Years', 'healthyVolunteers': False, 'eligibilityCriteria': 'Inclusion Criteria:\n\nParticipants must meet all the following criteria to be enrolled in this study:\n\n1. Participant is ≥ 18 years at the time of signing the informed consent form (ICF).\n2. Participant is willing and able to adhere to the study visit schedule and other protocol requirements.\n3. Participant has been participating in a luspatercept trial and continues to fulfill all the requirements of the parent protocol and the participant has been either:\n\n 1. Assigned to luspatercept treatment, continues to receive clinical benefit in the opinion of the investigator and should continue to receive luspatercept treatment, OR\n 2. Assigned to placebo arm in the parent protocol (at the time of unblinding or in follow-up) and should cross over to luspatercept treatment, OR\n 3. Assigned to the Follow-up Phase of the parent protocol, previously treated with luspatercept or placebo in the parent protocol who shall continue into LTPTFU phase in the rollover study until the follow-up commitments are met (unless requirements are met as per parent protocol to crossover to luspatercept treatment).\n4. Participant understands and voluntarily signs an informed consent document prior to any study-related assessments or procedures being conducted.\n5. Participant demonstrates compliance, as assessed by the investigator, with the parent study protocol requirements.\n6. Applies to on treatment Participants only- females of childbearing potential (FCBP) defined as a sexually mature woman who:\n\n1\\) has achieved menarche at some point, 2) has not undergone a hysterectomy or bilateral oophorectomy, or 3) has not been naturally postmenopausal (amenorrhea following cancer therapy or amenorrhea due to other medical reasons does not rule out childbearing potential) for at least 24 consecutive months (ie, has had menses at any time in the preceding 24 consecutive months) must:\n\n1. Have two negative pregnancy tests as verified by the investigator prior to starting study therapy. She must agree to ongoing pregnancy testing during the course of the study, and after end of study therapy. This applies even if the participant practices true abstinence from heterosexual contact.\n2. Agrees to use, and be able to comply with highly effective, contraception without interruption, 35 days prior to starting investigational product (IP), during the study therapy (including dose interruptions), and for 84 days after discontinuation of study therapy.\n\n 7\\. Applies to on treatment participants only- Male participants must:\n\na. Agrees to use a condom during sexual contact with a pregnant female or a female of childbearing potential while participating in the study, during dose interruptions and for at least 84 days following investigational product discontinuation even if he has undergone a successful vasectomy.\n\nExclusion Criteria:\n\nThe presence of any of the following will exclude a participant from enrollment:\n\n1. Applies to on treatment participants only- Concomitant use of any medications/procedures that are prohibited in the parent luspatercept protocol.\n2. Participant has met one or more criteria for study discontinuation as stipulated in the parent luspatercept protocol.\n3. Applies to on treatment participants only- More than 26 days between last luspatercept dose in the parent protocol and first dose into ACE-536-LTFU-001 protocol unless dose delay or dose discontinuation criteria met.\n4. Applies to on treatment participants only- Pregnant or breastfeeding females.\n5. Participant has any significant medical condition, laboratory abnormality, psychiatric illness, or is considered vulnerable by local regulations (eg, imprisoned or institutionalized) that would prevent the subject from participating in the study.\n6. Participant has any condition including the presence of laboratory abnormalities, which places the subject at unacceptable risk if he/she were to participate in the study.\n7. Participant has any condition that confounds the ability to interpret data from the study.'}, 'identificationModule': {'nctId': 'NCT04064060', 'briefTitle': 'A Study to Evaluate Long-term Safety in Participants Who Have Participated in Other Luspatercept (ACE-536) Clinical Trials', 'organization': {'class': 'INDUSTRY', 'fullName': 'Celgene'}, 'officialTitle': 'A Phase 3b, Open-label, Single-arm, Rollover Study to Evaluate Long-term Safety in Subjects Who Have Participated in Other Luspatercept (ACE-536) Clinical Trials', 'orgStudyIdInfo': {'id': 'ACE-536-LTFU-001'}, 'secondaryIdInfos': [{'id': 'U1111-1235-8123', 'type': 'REGISTRY', 'domain': 'WHO'}, {'id': '2022-502498-40', 'type': 'OTHER', 'domain': 'EU CTR'}]}, 'armsInterventionsModule': {'armGroups': [{'type': 'EXPERIMENTAL', 'label': 'ACE-536', 'description': "Luspatercept will be administered as a subcutaneous (SC) injection to participants by the study staff at the clinical site and administration will be documented in the subject's source record.", 'interventionNames': ['Drug: Luspatercept']}], 'interventions': [{'name': 'Luspatercept', 'type': 'DRUG', 'otherNames': ['ACE-536'], 'description': 'Luspatercept (ACE-536), an erythroid maturation agent, is a recombinant fusion protein consisting of a modified form of the extracellular domain (ECD) of the human activin receptor type IIB (ActRIIB) linked to the human immunoglobin G 1 (IgG1) Fc domain. ActRIIB receptor and its ligands are members of the transforming growth factor-β (TGF-β) superfamily. Members of the TGF-β superfamily ligands, through their binding to activin receptors, are involved in modulating the differentiation of late-stage erythrocyte precursors (normoblasts) in the bone marrow. Luspatercept for injection is formulated as a sterile, preservative-free, lyophilized cake/powder. Luspatercept for injection is available in 25 mg and 75 mg vials and when reconstituted with water for injection, each consists of 50 mg/mL luspatercept in a 10 mM citrate buffer-based solution', 'armGroupLabels': ['ACE-536']}]}, 'contactsLocationsModule': {'locations': [{'zip': '90027-6062', 'city': 'Los Angeles', 'state': 'California', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'name': 'Thomas Coates, Site 968', 'role': 'CONTACT', 'phone': '323-361-2352'}], 'facility': 'Childrens Hospital Los Angeles RHU', 'geoPoint': {'lat': 34.05223, 'lon': -118.24368}}, {'zip': '94609', 'city': 'Oakland', 'state': 'California', 'status': 'COMPLETED', 'country': 'United States', 'facility': 'Local Institution - 971', 'geoPoint': {'lat': 37.80437, 'lon': -122.2708}}, {'zip': '94305', 'city': 'Stanford', 'state': 'California', 'status': 'COMPLETED', 'country': 'United States', 'facility': 'Local Institution - 978', 'geoPoint': {'lat': 37.42411, 'lon': -122.16608}}, {'zip': '33612', 'city': 'Tampa', 'state': 'Florida', 'status': 'COMPLETED', 'country': 'United States', 'facility': 'Local Institution - 975', 'geoPoint': {'lat': 27.94752, 'lon': -82.45843}}, {'zip': '60611', 'city': 'Chicago', 'state': 'Illinois', 'status': 'COMPLETED', 'country': 'United States', 'facility': 'Local Institution - 970', 'geoPoint': {'lat': 41.85003, 'lon': -87.65005}}, {'zip': '02115', 'city': 'Boston', 'state': 'Massachusetts', 'status': 'COMPLETED', 'country': 'United States', 'facility': 'Local Institution - 973', 'geoPoint': {'lat': 42.35843, 'lon': -71.05977}}, {'zip': '48201', 'city': 'Detroit', 'state': 'Michigan', 'status': 'COMPLETED', 'country': 'United States', 'facility': 'Local Institution - 961', 'geoPoint': {'lat': 42.33143, 'lon': -83.04575}}, {'zip': '10065', 'city': 'New York', 'state': 'New York', 'status': 'COMPLETED', 'country': 'United States', 'facility': 'Local Institution - 969', 'geoPoint': {'lat': 40.71427, 'lon': -74.00597}}, {'zip': '44195', 'city': 'Cleveland', 'state': 'Ohio', 'status': 'ACTIVE_NOT_RECRUITING', 'country': 'United States', 'facility': 'Local Institution - 967', 'geoPoint': {'lat': 41.4995, 'lon': -81.69541}}, {'zip': '19104', 'city': 'Philadelphia', 'state': 'Pennsylvania', 'status': 'COMPLETED', 'country': 'United States', 'facility': 'Local Institution - 972', 'geoPoint': {'lat': 39.95238, 'lon': -75.16362}}, {'zip': '37232-5505', 'city': 'Nashville', 'state': 'Tennessee', 'status': 'WITHDRAWN', 'country': 'United States', 'facility': 'Vanderbilt - Ingram Cancer Center', 'geoPoint': {'lat': 36.16589, 'lon': -86.78444}}, {'zip': '77030', 'city': 'Houston', 'state': 'Texas', 'status': 'WITHDRAWN', 'country': 'United States', 'facility': 'The University of Texas - MD Anderson Cancer Center', 'geoPoint': {'lat': 29.76328, 'lon': -95.36327}}, {'zip': '4101', 'city': 'South Brisbane', 'state': 'Queensland', 'status': 'COMPLETED', 'country': 'Australia', 'facility': 'Local Institution - 100', 'geoPoint': {'lat': -27.48034, 'lon': 153.02049}}, {'zip': '5000', 'city': 'Adelaide', 'state': 'South Australia', 'status': 'RECRUITING', 'country': 'Australia', 'contacts': [{'name': 'Devendra Hiwase, Site 103', 'role': 'CONTACT', 'phone': '+61882223369'}], 'facility': 'Royal Adelaide Hospital', 'geoPoint': {'lat': -34.92866, 'lon': 138.59863}}, {'zip': '3168', 'city': 'Clayton', 'state': 'Victoria', 'status': 'COMPLETED', 'country': 'Australia', 'facility': 'Local Institution - 102', 'geoPoint': {'lat': -37.91667, 'lon': 145.11667}}, {'zip': '2050', 'city': 'Camperdown', 'status': 'RECRUITING', 'country': 'Australia', 'contacts': [{'name': 'Joy Ho, Site 101', 'role': 'CONTACT', 'phone': '+61295158031'}], 'facility': 'Royal Prince Alfred Hospital', 'geoPoint': {'lat': -33.88965, 'lon': 151.17642}}, {'zip': '2930', 'city': 'Brasschaat', 'status': 'COMPLETED', 'country': 'Belgium', 'facility': 'Local Institution - 182', 'geoPoint': {'lat': 51.2912, 'lon': 4.49182}}, {'zip': '8000', 'city': 'Bruges', 'status': 'COMPLETED', 'country': 'Belgium', 'facility': 'Local Institution - 180', 'geoPoint': {'lat': 51.20892, 'lon': 3.22424}}, {'zip': '9000', 'city': 'Ghent', 'status': 'COMPLETED', 'country': 'Belgium', 'facility': 'Local Institution - 183', 'geoPoint': {'lat': 51.05, 'lon': 3.71667}}, {'zip': '3000', 'city': 'Leuven', 'status': 'COMPLETED', 'country': 'Belgium', 'facility': 'Local Institution - 184', 'geoPoint': {'lat': 50.87959, 'lon': 4.70093}}, {'zip': '1797', 'city': 'Boulevard', 'state': 'Sofia', 'status': 'COMPLETED', 'country': 'Bulgaria', 'facility': 'Local Institution - 220'}, {'zip': '4002', 'city': 'Plovdiv', 'status': 'COMPLETED', 'country': 'Bulgaria', 'facility': 'Local Institution - 221', 'geoPoint': {'lat': 42.15387, 'lon': 24.75001}}, {'zip': 'M4N 3M5', 'city': 'Toronto', 'state': 'Ontario', 'status': 'COMPLETED', 'country': 'Canada', 'facility': 'Local Institution - 262', 'geoPoint': {'lat': 43.70643, 'lon': -79.39864}}, {'zip': 'M5G 2C4', 'city': 'Toronto', 'state': 'Ontario', 'status': 'COMPLETED', 'country': 'Canada', 'facility': 'Local Institution - 260', 'geoPoint': {'lat': 43.70643, 'lon': -79.39864}}, {'zip': 'M5G 2M9', 'city': 'Toronto', 'state': 'Ontario', 'status': 'COMPLETED', 'country': 'Canada', 'facility': 'Local Institution - 263', 'geoPoint': {'lat': 43.70643, 'lon': -79.39864}}, {'zip': '100730', 'city': 'Beijing', 'state': 'Beijing Municipality', 'status': 'WITHDRAWN', 'country': 'China', 'facility': 'Local Institution - 131', 'geoPoint': {'lat': 39.9075, 'lon': 116.39723}}, {'zip': '510515', 'city': 'Guangzhou', 'state': 'Guangdong', 'status': 'WITHDRAWN', 'country': 'China', 'facility': 'Local Institution - 135', 'geoPoint': {'lat': 23.11667, 'lon': 113.25}}, {'zip': '200233', 'city': 'Shanghai', 'state': 'Shanghai Municipality', 'status': 'WITHDRAWN', 'country': 'China', 'facility': 'Local Institution - 132', 'geoPoint': {'lat': 31.22222, 'lon': 121.45806}}, {'zip': '610041', 'city': 'Chengdu', 'state': 'Sichuan', 'status': 'WITHDRAWN', 'country': 'China', 'facility': 'Local Institution - 134', 'geoPoint': {'lat': 30.66667, 'lon': 104.06667}}, {'zip': '300020', 'city': 'Tianjin', 'state': 'Tianjin Municipality', 'status': 'WITHDRAWN', 'country': 'China', 'facility': 'Local Institution - 130', 'geoPoint': {'lat': 39.14222, 'lon': 117.17667}}, {'zip': '310009', 'city': 'Hangzhou', 'state': 'Zhejiang', 'status': 'WITHDRAWN', 'country': 'China', 'facility': 'Local Institution - 133', 'geoPoint': {'lat': 30.29365, 'lon': 120.16142}}, {'zip': '49033', 'city': 'Angers', 'status': 'COMPLETED', 'country': 'France', 'facility': 'Local Institution - 305', 'geoPoint': {'lat': 47.47156, 'lon': -0.55202}}, {'zip': '94010', 'city': 'Créteil', 'status': 'COMPLETED', 'country': 'France', 'facility': 'Local Institution - 300', 'geoPoint': {'lat': 48.79266, 'lon': 2.46569}}, {'zip': '38700', 'city': 'La Tronche', 'status': 'COMPLETED', 'country': 'France', 'facility': 'Local Institution - 310', 'geoPoint': {'lat': 45.20507, 'lon': 5.74629}}, {'zip': '59037', 'city': 'Lille', 'status': 'COMPLETED', 'country': 'France', 'facility': 'Local Institution - 306', 'geoPoint': {'lat': 50.63391, 'lon': 3.05512}}, {'zip': '13385', 'city': 'Marseille', 'status': 'COMPLETED', 'country': 'France', 'facility': 'Local Institution - 301', 'geoPoint': {'lat': 43.29695, 'lon': 5.38107}}, {'zip': '75010', 'city': 'Paris', 'status': 'COMPLETED', 'country': 'France', 'facility': 'Local Institution - 302', 'geoPoint': {'lat': 48.85341, 'lon': 2.3488}}, {'zip': '33604', 'city': 'Pessac', 'status': 'WITHDRAWN', 'country': 'France', 'facility': 'Local Institution - 307', 'geoPoint': {'lat': 44.80565, 'lon': -0.6324}}, {'zip': '69495', 'city': 'Pierre-Bénite', 'status': 'COMPLETED', 'country': 'France', 'facility': 'Local Institution - 304', 'geoPoint': {'lat': 45.70359, 'lon': 4.82424}}, {'zip': '67091', 'city': 'Strasbourg', 'status': 'COMPLETED', 'country': 'France', 'facility': 'Local Institution - 308', 'geoPoint': {'lat': 48.58392, 'lon': 7.74553}}, {'zip': '31059', 'city': 'Toulouse', 'status': 'COMPLETED', 'country': 'France', 'facility': 'Local Institution - 309', 'geoPoint': {'lat': 43.60426, 'lon': 1.44367}}, {'zip': '37044', 'city': 'Tours', 'status': 'WITHDRAWN', 'country': 'France', 'facility': 'Local Institution - 303', 'geoPoint': {'lat': 47.39484, 'lon': 0.70398}}, {'zip': '14195', 'city': 'Berlin', 'status': 'COMPLETED', 'country': 'Germany', 'facility': 'Local Institution - 341', 'geoPoint': {'lat': 52.52437, 'lon': 13.41053}}, {'zip': '01307', 'city': 'Dresden', 'status': 'COMPLETED', 'country': 'Germany', 'facility': 'Local Institution - 348', 'geoPoint': {'lat': 51.05089, 'lon': 13.73832}}, {'zip': '40225', 'city': 'Düsseldorf', 'status': 'COMPLETED', 'country': 'Germany', 'facility': 'Local Institution - 345', 'geoPoint': {'lat': 51.22172, 'lon': 6.77616}}, {'zip': '40479', 'city': 'Düsseldorf', 'status': 'COMPLETED', 'country': 'Germany', 'facility': 'Local Institution - 346', 'geoPoint': {'lat': 51.22172, 'lon': 6.77616}}, {'zip': '06120', 'city': 'Halle', 'status': 'COMPLETED', 'country': 'Germany', 'facility': 'Local Institution - 343', 'geoPoint': {'lat': 51.48158, 'lon': 11.97947}}, {'zip': '22081', 'city': 'Hamburg', 'status': 'COMPLETED', 'country': 'Germany', 'facility': 'Local Institution - 342', 'geoPoint': {'lat': 53.55073, 'lon': 9.99302}}, {'zip': '30625', 'city': 'Hanover', 'status': 'COMPLETED', 'country': 'Germany', 'facility': 'Local Institution - 344', 'geoPoint': {'lat': 52.37052, 'lon': 9.73322}}, {'zip': '04103', 'city': 'Leipzig', 'status': 'WITHDRAWN', 'country': 'Germany', 'facility': 'Local Institution - 349', 'geoPoint': {'lat': 51.33962, 'lon': 12.37129}}, {'zip': '55131', 'city': 'Mainz', 'status': 'COMPLETED', 'country': 'Germany', 'facility': 'Local Institution - 340', 'geoPoint': {'lat': 49.98185, 'lon': 8.28008}}, {'zip': '81675', 'city': 'München', 'status': 'COMPLETED', 'country': 'Germany', 'facility': 'Local Institution - 347', 'geoPoint': {'lat': 51.60698, 'lon': 13.31243}}, {'zip': '115 27', 'city': 'Athens', 'status': 'RECRUITING', 'country': 'Greece', 'contacts': [{'name': 'Antonis Kattamis, Site 382', 'role': 'CONTACT', 'phone': '+302107467772 0(000)'}], 'facility': "Aghia Sophia' Children's General Hospital of Athens", 'geoPoint': {'lat': 37.98376, 'lon': 23.72784}}, {'zip': '115 27', 'city': 'Athens', 'status': 'RECRUITING', 'country': 'Greece', 'contacts': [{'name': 'Maria Dimopoulou, Site 380', 'role': 'CONTACT'}], 'facility': 'Laiko General Hospital of Athens - Center of Thalassemia', 'geoPoint': {'lat': 37.98376, 'lon': 23.72784}}, {'zip': '11527', 'city': 'Athens', 'status': 'COMPLETED', 'country': 'Greece', 'facility': 'Local Institution - 384', 'geoPoint': {'lat': 37.98376, 'lon': 23.72784}}, {'zip': '26500', 'city': 'Rio Patras', 'status': 'COMPLETED', 'country': 'Greece', 'facility': 'Local Institution - 383'}, {'zip': '54642', 'city': 'Thessaloniki', 'status': 'COMPLETED', 'country': 'Greece', 'facility': 'Local Institution - 381', 'geoPoint': {'lat': 40.64072, 'lon': 22.93493}}, {'zip': '1834111', 'city': 'Afula', 'status': 'COMPLETED', 'country': 'Israel', 'facility': 'Local Institution - 425', 'geoPoint': {'lat': 32.60907, 'lon': 35.2892}}, {'zip': '3109601', 'city': 'Haifa', 'status': 'COMPLETED', 'country': 'Israel', 'facility': 'Local Institution - 420', 'geoPoint': {'lat': 32.81303, 'lon': 34.99928}}, {'zip': '91031', 'city': 'Jerusalem', 'status': 'COMPLETED', 'country': 'Israel', 'facility': 'Local Institution - 422', 'geoPoint': {'lat': 31.76904, 'lon': 35.21633}}, {'zip': '91120', 'city': 'Jerusalem', 'status': 'COMPLETED', 'country': 'Israel', 'facility': 'Local Institution - 424', 'geoPoint': {'lat': 31.76904, 'lon': 35.21633}}, {'zip': '22100', 'city': 'Nahariya', 'status': 'COMPLETED', 'country': 'Israel', 'facility': 'Local Institution - 421', 'geoPoint': {'lat': 33.00892, 'lon': 35.09814}}, {'zip': '49100', 'city': 'Petah Tikva', 'status': 'COMPLETED', 'country': 'Israel', 'facility': 'Local Institution - 423', 'geoPoint': {'lat': 32.08707, 'lon': 34.88747}}, {'zip': '50134', 'city': 'Florence', 'state': 'Tuscany', 'status': 'ACTIVE_NOT_RECRUITING', 'country': 'Italy', 'facility': 'Local Institution - 478', 'geoPoint': {'lat': 43.77925, 'lon': 11.24626}}, {'zip': '50139', 'city': 'Florence', 'state': 'Tuscany', 'status': 'ACTIVE_NOT_RECRUITING', 'country': 'Italy', 'facility': 'Local Institution - 471', 'geoPoint': {'lat': 43.77925, 'lon': 11.24626}}, {'zip': '15100', 'city': 'Allessandria', 'status': 'COMPLETED', 'country': 'Italy', 'facility': 'Local Institution - 470'}, {'zip': '40138', 'city': 'Bologna', 'status': 'COMPLETED', 'country': 'Italy', 'facility': 'Local Institution - 464', 'geoPoint': {'lat': 44.49381, 'lon': 11.33875}}, {'zip': '72100', 'city': 'Brindisi', 'status': 'COMPLETED', 'country': 'Italy', 'facility': 'Local Institution - 466', 'geoPoint': {'lat': 40.63215, 'lon': 17.93607}}, {'zip': '09121', 'city': 'Cagliari', 'status': 'COMPLETED', 'country': 'Italy', 'facility': 'Local Institution - 477', 'geoPoint': {'lat': 39.23054, 'lon': 9.11917}}, {'zip': '44124', 'city': 'Ferrara', 'status': 'COMPLETED', 'country': 'Italy', 'facility': 'Local Institution - 462', 'geoPoint': {'lat': 44.83804, 'lon': 11.62057}}, {'zip': '16128', 'city': 'Genoa', 'status': 'RECRUITING', 'country': 'Italy', 'contacts': [{'name': 'Manuela Balocco, Site 476', 'role': 'CONTACT', 'phone': '+390105634557'}], 'facility': 'Ente Ospedaliero Ospedali Galliera - Centro della Microcitemia e delle Anemie Congenite', 'geoPoint': {'lat': 44.40478, 'lon': 8.94439}}, {'zip': '73100', 'city': 'Lecce', 'status': 'COMPLETED', 'country': 'Italy', 'facility': 'Local Institution - 473', 'geoPoint': {'lat': 40.35481, 'lon': 18.17244}}, {'zip': '20122', 'city': 'Milan', 'status': 'RECRUITING', 'country': 'Italy', 'contacts': [{'name': 'Maria Domenica Cappellini, Site 467', 'role': 'CONTACT', 'phone': '+390250320288'}], 'facility': "Maggiore Polyclinic Hospital, IRCCS Ca' Granda", 'geoPoint': {'lat': 42.78235, 'lon': 12.59836}}, {'zip': '41124', 'city': 'Modena', 'status': 'COMPLETED', 'country': 'Italy', 'facility': 'Local Institution - 479', 'geoPoint': {'lat': 44.64783, 'lon': 10.92539}}, {'zip': '80131', 'city': 'Napoli', 'status': 'RECRUITING', 'country': 'Italy', 'contacts': [{'name': 'Paolo Ricchi, Site 475', 'role': 'CONTACT', 'phone': '390817472256'}], 'facility': 'AORN A Cardarelli', 'geoPoint': {'lat': 40.87618, 'lon': 14.5195}}, {'zip': '80131', 'city': 'Napoli', 'status': 'RECRUITING', 'country': 'Italy', 'contacts': [{'name': 'Silverio Perrotta, Site 461', 'role': 'CONTACT', 'phone': '+0390815665421 0 000'}], 'facility': "AOU dell'Universita degli Studi della Campania Luigi Vanvitelli", 'geoPoint': {'lat': 40.87618, 'lon': 14.5195}}, {'zip': '10043', 'city': 'Orbassano', 'status': 'RECRUITING', 'country': 'Italy', 'contacts': [{'name': 'Giovanni Battista Ferrero, Site 460', 'role': 'CONTACT'}], 'facility': 'Azienda Ospedaliero Universitaria S. Luigi Gonzaga', 'geoPoint': {'lat': 45.00547, 'lon': 7.53813}}, {'zip': '27100', 'city': 'Pavia', 'status': 'COMPLETED', 'country': 'Italy', 'facility': 'Local Institution - 469', 'geoPoint': {'lat': 45.19205, 'lon': 9.15917}}, {'zip': '89124', 'city': 'Reggio Calabria', 'status': 'COMPLETED', 'country': 'Italy', 'facility': 'Local Institution - 468', 'geoPoint': {'lat': 38.11047, 'lon': 15.66129}}, {'zip': '133', 'city': 'Roma', 'status': 'COMPLETED', 'country': 'Italy', 'facility': 'Local Institution - 465', 'geoPoint': {'lat': 44.99364, 'lon': 11.10642}}, {'zip': '20089', 'city': 'Rozzano', 'status': 'WITHDRAWN', 'country': 'Italy', 'facility': 'Local Institution - 474', 'geoPoint': {'lat': 45.38193, 'lon': 9.1559}}, {'zip': '21100', 'city': 'Varese', 'status': 'COMPLETED', 'country': 'Italy', 'facility': 'Local Institution - 472', 'geoPoint': {'lat': 45.82058, 'lon': 8.82511}}, {'zip': '37134', 'city': 'Verona', 'status': 'COMPLETED', 'country': 'Italy', 'facility': 'Local Institution - 463', 'geoPoint': {'lat': 45.43854, 'lon': 10.9938}}, {'zip': '460-0001', 'city': 'Nagoya', 'state': 'Aichi-ken', 'status': 'COMPLETED', 'country': 'Japan', 'facility': 'Local Institution - 610', 'geoPoint': {'lat': 35.18147, 'lon': 136.90641}}, {'zip': '296-0041', 'city': 'Kamogawa', 'state': 'Chiba', 'status': 'COMPLETED', 'country': 'Japan', 'facility': 'Local Institution - 601', 'geoPoint': {'lat': 35.0969, 'lon': 140.1003}}, {'zip': '790-8524', 'city': 'Matsuyama', 'state': 'Ehime', 'status': 'RECRUITING', 'country': 'Japan', 'contacts': [{'name': 'Tomoaki Fujisaki, Site 606', 'role': 'CONTACT', 'phone': '810899241111'}], 'facility': 'Matsuyama Red Cross Hospital', 'geoPoint': {'lat': 33.83916, 'lon': 132.76574}}, {'zip': '503-8502', 'city': 'Ōgaki', 'state': 'Gifu', 'status': 'RECRUITING', 'country': 'Japan', 'contacts': [{'name': 'Hiroshi Kosugi, Site 608', 'role': 'CONTACT', 'phone': '81584813341'}], 'facility': 'Ogaki Municipal Hospital', 'geoPoint': {'lat': 35.35, 'lon': 136.61667}}, {'zip': '6708540', 'city': 'Himeji', 'state': 'Hyōgo', 'status': 'RECRUITING', 'country': 'Japan', 'contacts': [{'name': 'Yasushi Hiramatsu, Site 614', 'role': 'CONTACT'}], 'facility': 'Japanese Red Cross Society Himeji Hospital', 'geoPoint': {'lat': 34.81667, 'lon': 134.7}}, {'zip': '317-0077', 'city': 'Hitachi', 'state': 'Ibaraki', 'status': 'ACTIVE_NOT_RECRUITING', 'country': 'Japan', 'facility': 'Local Institution - 605', 'geoPoint': {'lat': 36.6, 'lon': 140.65}}, {'zip': '252-0329', 'city': 'Sagamihara', 'state': 'Kanagawa', 'status': 'RECRUITING', 'country': 'Japan', 'contacts': [{'name': 'Takahiro Suzuki, Site 603', 'role': 'CONTACT', 'phone': '+0285587353 00000-00'}], 'facility': 'Kitasato University Hospital', 'geoPoint': {'lat': 35.56707, 'lon': 139.24167}}, {'zip': '980-8574', 'city': 'Sendai', 'state': 'Miyagi', 'status': 'WITHDRAWN', 'country': 'Japan', 'facility': 'Local Institution - 0979', 'geoPoint': {'lat': 38.26667, 'lon': 140.86667}}, {'zip': '980-8574', 'city': 'Sendai', 'state': 'Miyagi', 'status': 'RECRUITING', 'country': 'Japan', 'contacts': [{'name': 'Koichi Onodera, Site 607', 'role': 'CONTACT'}], 'facility': 'Tohoku University Hospital', 'geoPoint': {'lat': 38.26667, 'lon': 140.86667}}, {'zip': '8528511', 'city': 'Nagasaki', 'state': 'Nagasaki', 'status': 'WITHDRAWN', 'country': 'Japan', 'facility': 'Local Institution - 611', 'geoPoint': {'lat': 32.75, 'lon': 129.88333}}, {'zip': '150-8935', 'city': 'Shibuya City', 'state': 'Tokyo', 'status': 'RECRUITING', 'country': 'Japan', 'contacts': [{'name': 'Nobuhiro Tsukada, Site 602', 'role': 'CONTACT', 'phone': '81334000104'}], 'facility': 'Japanese Red Cross Medical Center', 'geoPoint': {'lat': 35.6589, 'lon': 139.70665}}, {'zip': '141-8625', 'city': 'Shinagawa City', 'state': 'Tokyo', 'status': 'RECRUITING', 'country': 'Japan', 'contacts': [{'name': 'Motoshi Ichikawa, Site 600', 'role': 'CONTACT', 'phone': '03-3448-6111'}], 'facility': 'NTT Medical Center Tokyo'}, {'zip': '260-0852', 'city': 'Chiba', 'status': 'COMPLETED', 'country': 'Japan', 'facility': 'Local Institution - 612', 'geoPoint': {'lat': 35.6, 'lon': 140.11667}}, {'zip': '247-8533', 'city': 'Kamakura', 'status': 'RECRUITING', 'country': 'Japan', 'contacts': [{'name': 'Shuku sato, Site 613', 'role': 'CONTACT', 'phone': '+81-467-46-1717'}], 'facility': 'Shonan Kamakura General Hospital', 'geoPoint': {'lat': 35.31085, 'lon': 139.54698}}, {'zip': '545-8586', 'city': 'Osaka', 'status': 'RECRUITING', 'country': 'Japan', 'contacts': [{'name': 'Yasuhiro Nakashima, Site 609', 'role': 'CONTACT'}], 'facility': 'Osaka Metropolitan University Hospital', 'geoPoint': {'lat': 34.69379, 'lon': 135.50107}}, {'zip': '589-8511', 'city': 'Osaka', 'status': 'ACTIVE_NOT_RECRUITING', 'country': 'Japan', 'facility': 'Local Institution - 604', 'geoPoint': {'lat': 34.69379, 'lon': 135.50107}}, {'zip': '00961', 'city': 'Hazmiyeh', 'status': 'RECRUITING', 'country': 'Lebanon', 'contacts': [{'name': 'Ali Taher, Site 500', 'role': 'CONTACT', 'phone': '+9613755669 000000.0'}], 'facility': 'Chronic Care Center', 'geoPoint': {'lat': 33.85534, 'lon': 35.53589}}, {'zip': '80100', 'city': 'Johor Bahru', 'state': 'Johor', 'status': 'COMPLETED', 'country': 'Malaysia', 'facility': 'Local Institution - 545', 'geoPoint': {'lat': 1.4655, 'lon': 103.7578}}, {'zip': '05460', 'city': 'Alor Star', 'state': 'Kedah', 'status': 'RECRUITING', 'country': 'Malaysia', 'contacts': [{'name': 'Hong Keng Liew, Site 542', 'role': 'CONTACT', 'phone': '6047406191'}], 'facility': 'Hospital Sultanah Bahiyah', 'geoPoint': {'lat': 6.12104, 'lon': 100.36014}}, {'zip': '59100', 'city': 'Kuala Lumpur', 'state': 'Kuala Lumpur', 'status': 'RECRUITING', 'country': 'Malaysia', 'contacts': [{'name': 'Ping Chong Bee, Site 544', 'role': 'CONTACT', 'phone': '+60123048771'}], 'facility': 'University Malaya Medical Centre', 'geoPoint': {'lat': 3.1412, 'lon': 101.68653}}, {'zip': '30990', 'city': 'Ipoh', 'state': 'Perak', 'status': 'RECRUITING', 'country': 'Malaysia', 'contacts': [{'name': 'Kamini Kirubamoorthy, Site 546', 'role': 'CONTACT', 'phone': '+60193255800'}], 'facility': 'Hospital Raja Permaisuri Bainun', 'geoPoint': {'lat': 4.5841, 'lon': 101.0829}}, {'zip': '88586', 'city': 'Kota Kinabalu', 'state': 'Sabah', 'status': 'RECRUITING', 'country': 'Malaysia', 'contacts': [{'name': 'Lily Wong, Site 543', 'role': 'CONTACT', 'phone': '6088517507'}], 'facility': 'Queen Elizabeth Hospital', 'geoPoint': {'lat': 5.9749, 'lon': 116.0724}}, {'zip': '93586', 'city': 'Kuching', 'state': 'Sarawak', 'status': 'RECRUITING', 'country': 'Malaysia', 'contacts': [{'name': 'Lee Ping Chew, Site 540', 'role': 'CONTACT', 'phone': '+60165518129'}], 'facility': 'Hospital Umum Sarawak', 'geoPoint': {'lat': 1.55, 'lon': 110.33333}}, {'zip': '1081 HV', 'city': 'Amsterdam', 'status': 'COMPLETED', 'country': 'Netherlands', 'facility': 'Local Institution - 580', 'geoPoint': {'lat': 52.37403, 'lon': 4.88969}}, {'zip': '48903', 'city': 'Barakaldo', 'status': 'COMPLETED', 'country': 'Spain', 'facility': 'Local Institution - 681', 'geoPoint': {'lat': 43.29639, 'lon': -2.98813}}, {'zip': '08908', 'city': 'Barcelona', 'status': 'COMPLETED', 'country': 'Spain', 'facility': 'Local Institution - 686', 'geoPoint': {'lat': 41.38879, 'lon': 2.15899}}, {'zip': '8035', 'city': 'Barcelona', 'status': 'COMPLETED', 'country': 'Spain', 'facility': 'Local Institution - 685', 'geoPoint': {'lat': 41.38879, 'lon': 2.15899}}, {'zip': '28028', 'city': 'Madrid', 'status': 'COMPLETED', 'country': 'Spain', 'facility': 'Local Institution - 687', 'geoPoint': {'lat': 40.4165, 'lon': -3.70256}}, {'zip': '33011', 'city': 'Oviedo', 'status': 'COMPLETED', 'country': 'Spain', 'facility': 'Local Institution - 682', 'geoPoint': {'lat': 43.36029, 'lon': -5.84476}}, {'zip': '37007', 'city': 'Salamanca', 'status': 'COMPLETED', 'country': 'Spain', 'facility': 'Local Institution - 684', 'geoPoint': {'lat': 40.96882, 'lon': -5.66388}}, {'zip': '41013', 'city': 'Seville', 'status': 'COMPLETED', 'country': 'Spain', 'facility': 'Local Institution - 680', 'geoPoint': {'lat': 37.38283, 'lon': -5.97317}}, {'zip': '46026', 'city': 'Valencia', 'status': 'COMPLETED', 'country': 'Spain', 'facility': 'Local Institution - 683', 'geoPoint': {'lat': 39.47391, 'lon': -0.37966}}, {'zip': '413 45', 'city': 'Gothenburg', 'status': 'COMPLETED', 'country': 'Sweden', 'facility': 'Local Institution - 720', 'geoPoint': {'lat': 57.70716, 'lon': 11.96679}}, {'zip': 'SE-221 85', 'city': 'Lund', 'status': 'COMPLETED', 'country': 'Sweden', 'facility': 'Local Institution - 722', 'geoPoint': {'lat': 55.70584, 'lon': 13.19321}}, {'zip': '141 86', 'city': 'Stockholm', 'status': 'COMPLETED', 'country': 'Sweden', 'facility': 'Local Institution - 721', 'geoPoint': {'lat': 59.32938, 'lon': 18.06871}}, {'zip': '807', 'city': 'Kaohsiung, San Ming Dist.', 'status': 'COMPLETED', 'country': 'Taiwan', 'facility': 'Local Institution - 760', 'geoPoint': {'lat': 22.61626, 'lon': 120.31333}}, {'zip': '40447', 'city': 'Taichung', 'status': 'RECRUITING', 'country': 'Taiwan', 'contacts': [{'name': 'Ching-Tien Peng, Site 762', 'role': 'CONTACT', 'phone': '886422052121ext4636'}], 'facility': 'China Medical University Hospital', 'geoPoint': {'lat': 24.1469, 'lon': 120.6839}}, {'zip': '100225', 'city': 'Taipei', 'status': 'COMPLETED', 'country': 'Taiwan', 'facility': 'Local Institution - 761', 'geoPoint': {'lat': 25.05306, 'lon': 121.52639}}, {'zip': '10330', 'city': 'Bangkok', 'status': 'RECRUITING', 'country': 'Thailand', 'contacts': [{'name': 'Pranee Sutcharitchan, Site 800', 'role': 'CONTACT', 'phone': '+66022564564'}], 'facility': 'Chulalongkorn University Faculty of Medicine - King Chulalongkorn Memorial Hospital', 'geoPoint': {'lat': 13.75398, 'lon': 100.50144}}, {'zip': '10700', 'city': 'Bangkok', 'status': 'RECRUITING', 'country': 'Thailand', 'contacts': [{'name': 'Vip Viprakasit, Site 802', 'role': 'CONTACT', 'phone': '6624122113'}], 'facility': 'Siriraj Hospital Mahidol University', 'geoPoint': {'lat': 13.75398, 'lon': 100.50144}}, {'zip': '50200', 'city': 'Chiang Mai', 'status': 'RECRUITING', 'country': 'Thailand', 'contacts': [{'name': 'Adisak Tantiworawit, Site 801', 'role': 'CONTACT', 'phone': '+66815688875'}], 'facility': 'Chiang Mai University - Maharaj Nakorn Chiang Mai Hospital', 'geoPoint': {'lat': 18.79038, 'lon': 98.98468}}, {'zip': '4031', 'city': 'Sousse', 'status': 'RECRUITING', 'country': 'Tunisia', 'contacts': [{'name': 'Khelif Abderahim, Site 840', 'role': 'CONTACT', 'phone': '+21673102503'}], 'facility': 'University Hospital Farhat Hached', 'geoPoint': {'lat': 35.82539, 'lon': 10.63699}}, {'zip': '1006', 'city': 'Tunis', 'status': 'RECRUITING', 'country': 'Tunisia', 'contacts': [{'name': 'Monia Ouederni, Site 841', 'role': 'CONTACT', 'phone': '+21693184151 0000 00'}], 'facility': 'Bone Marrow Transplant Center', 'geoPoint': {'lat': 36.81897, 'lon': 10.16579}}, {'zip': '1008', 'city': 'Tunis', 'status': 'RECRUITING', 'country': 'Tunisia', 'contacts': [{'name': 'Karima Kacem, Site 842', 'role': 'CONTACT'}], 'facility': 'Aziza Othmana Hospital', 'geoPoint': {'lat': 36.81897, 'lon': 10.16579}}, {'zip': '1008', 'city': 'Tunis', 'status': 'RECRUITING', 'country': 'Tunisia', 'contacts': [{'name': "Fehmi M'Sadk, Site 843", 'role': 'CONTACT', 'phone': '+21671393490'}], 'facility': 'Military Hospital of Tunis', 'geoPoint': {'lat': 36.81897, 'lon': 10.16579}}, {'zip': '01130', 'city': 'Adana', 'status': 'COMPLETED', 'country': 'Turkey (Türkiye)', 'facility': 'Local Institution - 881', 'geoPoint': {'lat': 36.98615, 'lon': 35.32531}}, {'zip': '06590', 'city': 'Ankara', 'status': 'COMPLETED', 'country': 'Turkey (Türkiye)', 'facility': 'Local Institution - 885', 'geoPoint': {'lat': 39.91987, 'lon': 32.85427}}, {'zip': '34093', 'city': 'Istanbul', 'status': 'COMPLETED', 'country': 'Turkey (Türkiye)', 'facility': 'Local Institution - 882', 'geoPoint': {'lat': 41.01384, 'lon': 28.94966}}, {'zip': '34098', 'city': 'Istanbul', 'status': 'COMPLETED', 'country': 'Turkey (Türkiye)', 'facility': 'Local Institution - 884', 'geoPoint': {'lat': 41.01384, 'lon': 28.94966}}, {'zip': '35100', 'city': 'Izmir', 'status': 'COMPLETED', 'country': 'Turkey (Türkiye)', 'facility': 'Local Institution - 880', 'geoPoint': {'lat': 38.41273, 'lon': 27.13838}}, {'zip': '33343', 'city': 'Mersin', 'status': 'COMPLETED', 'country': 'Turkey (Türkiye)', 'facility': 'Local Institution - 883', 'geoPoint': {'lat': 36.81196, 'lon': 34.63886}}, {'zip': 'AB25 2ZN', 'city': 'Aberdeen', 'status': 'COMPLETED', 'country': 'United Kingdom', 'facility': 'Local Institution - 925', 'geoPoint': {'lat': 57.14369, 'lon': -2.09814}}, {'zip': 'LS9 7TF', 'city': 'Leeds', 'status': 'WITHDRAWN', 'country': 'United Kingdom', 'facility': 'Local Institution - 921', 'geoPoint': {'lat': 53.79648, 'lon': -1.54785}}, {'zip': 'E1 1BB', 'city': 'London', 'status': 'COMPLETED', 'country': 'United Kingdom', 'facility': 'Local Institution - 923', 'geoPoint': {'lat': 51.50853, 'lon': -0.12574}}, {'zip': 'N19 5NF', 'city': 'London', 'status': 'RECRUITING', 'country': 'United Kingdom', 'contacts': [{'name': 'Emma Drasar, Site 920', 'role': 'CONTACT', 'phone': '+4402072723070'}], 'facility': 'Whittington Hospital', 'geoPoint': {'lat': 51.50853, 'lon': -0.12574}}, {'zip': 'NW1 2BU', 'city': 'London', 'status': 'RECRUITING', 'country': 'United Kingdom', 'contacts': [{'name': 'John Porter, Site 922', 'role': 'CONTACT', 'phone': '8076846044'}], 'facility': 'University College London Hospitals NHS Foundation Trust - University College Hospital', 'geoPoint': {'lat': 51.50853, 'lon': -0.12574}}, {'zip': 'SE1 9RT', 'city': 'London', 'status': 'COMPLETED', 'country': 'United Kingdom', 'facility': 'Local Institution - 928', 'geoPoint': {'lat': 51.50853, 'lon': -0.12574}}, {'zip': 'SE5 9RS', 'city': 'London', 'status': 'COMPLETED', 'country': 'United Kingdom', 'facility': 'Local Institution - 924', 'geoPoint': {'lat': 51.50853, 'lon': -0.12574}}, {'zip': 'OX3 7LE', 'city': 'Oxford', 'status': 'WITHDRAWN', 'country': 'United Kingdom', 'facility': 'Local Institution - 929', 'geoPoint': {'lat': 51.75222, 'lon': -1.25596}}, {'zip': 'NG17 4JL', 'city': 'Sutton in Ashfield', 'status': 'WITHDRAWN', 'country': 'United Kingdom', 'facility': 'Local Institution - 926', 'geoPoint': {'lat': 53.12542, 'lon': -1.26135}}], 'centralContacts': [{'name': 'BMS Study Connect Contact Center www.BMSStudyConnect.com', 'role': 'CONTACT', 'email': 'Clinical.Trials@bms.com', 'phone': '855-907-3286'}], 'overallOfficials': [{'name': 'Bristol-Myers Squibb', 'role': 'STUDY_DIRECTOR', 'affiliation': 'Bristol-Myers Squibb'}]}, 'ipdSharingStatementModule': {'url': 'https://www.bms.com/researchers-and-partners/clinical-trials-and-research/disclosure-commitment.html', 'infoTypes': ['STUDY_PROTOCOL', 'SAP', 'CSR'], 'timeFrame': 'See Plan Description', 'ipdSharing': 'YES', 'description': "BMS will provide access to individual anonymized participant data upon request from qualified researchers, and subject to certain criteria.\n\nAdditional information regarding Bristol Myer Squibb's data sharing policy and process can be found at: https://www.bms.com/researchers-and-partners/clinical-trials-and-research/disclosurecommitment.html", 'accessCriteria': 'See Plan Description'}, 'sponsorCollaboratorsModule': {'leadSponsor': {'name': 'Celgene', 'class': 'INDUSTRY'}, 'responsibleParty': {'type': 'SPONSOR'}}}}